FDA PMA
FDA Class 3
Approved
🇺🇸 United States
Implant, Cochlear
PMA: P970051
·
Supplement: S208
·
Decision Apr 29, 2022
Classifications
1
FEI Numbers
22
Registration Numbers
22
Basic Information
- Device Name
- Implant, Cochlear
- Trade Name
- Nucleus® 24 Cochlear Implant System
- PMA Number
- P970051
- Supplement Number
- S208
- Device Class
- FDA Class 3
- Product Code
- MCM
- Generic Name
- Implant, cochlear
- Medical Specialty
- Unknown
- Advisory Committee
- Ear, Nose, Throat
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- April 29, 2022
- Date Received
- January 31, 2022
- Supplement Type
- Real-Time Process
- Supplement Reason
- Change Design/Components/Specifications/Material
- Expedited Review
- N
Advisory Committee Statement
Approval for modification to Cochlear Research Platform Software resulting in version 2.0 of the software. This software update makes minor performance changes to existing electrocochleography functionality and implements a new software design to allow for introduction of future functionality.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| MCM | Implant, Cochlear | FDA class 3 | Unknown |